Mudryk could return on Wednesday after drugs suspension

EuroNewsletter newsroom brief · 53d ago · 1 min read · via bbc.co.uk

Mykhailo Mudryk could return to action following 20 months on the sidelines on Wednesday after being named in Chelsea's squad to play Juventus in a friendly in Hong Kong.

Mykhailo Mudryk's potential return to action after a 20-month suspension due to a drugs ban is significant for Chelsea and its fans, particularly in the European audience. The Ukrainian winger's comeback could provide a much-needed boost to the team's performance, and his inclusion in the squad for the friendly match against Juventus in Hong Kong is a positive sign. As a key player, Mudryk's return could impact Chelsea's strategy and overall team dynamics.

The European football community will be watching Mudryk's comeback closely, given the intense competition in the English Premier League and the Champions League. Chelsea's performance in these tournaments will be crucial in determining their standings, and Mudryk's contribution could be a deciding factor. The friendly match against Juventus will be an opportunity for Mudryk to regain his footing and for the team to assess his current form and readiness for the upcoming season.

As Mudryk prepares to return to action, fans and analysts will be watching his performance closely, looking for signs of his previous form and ability to integrate with the team. The outcome of the friendly match against Juventus will provide valuable insights into Chelsea's strengths and weaknesses, and Mudryk's role in the team's strategy. With the new season approaching, Mudryk's successful return could be a key factor in Chelsea's bid for success in European competitions, making his comeback a significant story to follow in the coming weeks.

Originally reported by bbc.co.uk. EuroNewsletter adds analysis for general news readers.

Originally reported by bbc.co.uk. EuroNewsletter curates and briefs the general news stories that matter. Our editorial policy →
Get the daily euro signal:

More from EuroNewsletter

Across the eCorp newsroom network

Part of the eCorp network